UNSPSC 51281666: Spectinomycin dihydrochloride

This classification denotes an aminoglycoside antibiotic with the molecular formula C14H24N2O7.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 296JEI210Z, chemically known as 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, dihydrochloride, but more generally known as spectinomycin dihydrochloride, which bears US NIH Compound Identifier 2021.

European Medicines Agency schedules spectinomycin dihydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10614MIG. Most nations, for tariff purposes, schedule spectinomycin dihydrochloride under HS 29419000. SMILES: C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O.CL.CL.

UNSPSC 51281666 Spectinomycin dihydrochloride is a Commodity code for a specific pharmaceutical product, though state and local governments show minimal recent solicitation activity directly under this narrow code. The two recent opportunities tagged to this code do not align with spectinomycin procurement; instead, they reflect broader pharmaceutical supply contracting where state and local health agencies acquire multiple drugs and medical supplies through piggyback arrangements and competitive bids. The Illinois Department of Public Health awarded a pharmaceutical warehouse contract to Chartwell Rx LLC for doxycycline hyclate and ciprofloxacin hydrochloride, while Seminole County, Florida solicited naloxone and drug deactivation systems. State and local governments purchase pharmaceuticals through both cooperative purchasing vehicles (such as MMCAP Infuse consortia) and direct competitive bidding, often bundling multiple products into single procurements. Issuing bodies include state health departments and county health agencies.

Activity appears concentrated in the Southeast and Midwest. The Illinois Department of Public Health posted a completed award in August 2026 valued at $2,999,999.11 over the full contract term through an IFB process, while Seminole County, Florida released an IFB in June 2026 for annual purchases of 1,900 units of naloxone and 800 safe drug deactivation systems (response deadline July 26, 2023). The Illinois opportunity was a piggyback procurement through an existing cooperative vehicle, whereas the Seminole County opportunity was a direct county IFB. Neither recent posting reflects active demand for spectinomycin dihydrochloride specifically; the code tag does not match the actual pharmaceutical products being solicited, suggesting either misclassification by the issuing bodies or that spectinomycin procurement occurs outside of the recent opportunities captured here.